Purchase Order 75N98025P00521
Award Date 12/3/24
Potential Completion Date 12/3/26
Potential Value $8.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Office of Logistics and Acquisition Operations awarded a Blanket Purchase Agreement (BPA) call to Qiagen, LLC on June 10, 2024, for the procurement of chemicals. This firm fixed price contract carries a ceiling value of approximately $20.95K and is scheduled for ultimate completion on April 30, 2025. The award was made without a set-aside designation, reflecting Qiagen's ability to compete in the open federal marketplace. Performance will take place at the company's Germantown, Maryland...
- The U.S. federal government awarded a Firm Fixed Price Purchase Order contract worth $22,732.35 to Qiagen, LLC, a division of the international company Qiagen N.V., for the provision of DNA isolation kits. The contract has an ultimate completion date of June 1, 2018 and was awarded on May 3, 2018 by the Acquisitions agency, which is a civilian agency. Qiagen, LLC is a foreign-owned, for-profit manufacturer that has provided various products and services to support federal agencies' biomedical...
- This federal contract award was made by a civilian federal agency to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the purchase of scientific consumables, such as DNA/RNA extraction kits, next-generation sequencing equipment, and bioinformatics software, with a ceiling value of $6,162.64. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Qiagen's ability to compete effectively in the federal...
- Qiagen, LLC received a $29,166.25 firm fixed-price purchase order from the NIH Clinical Center, awarded on January 1, 2026, with a completion date of December 31, 2026. This contract carries no set-aside designation, allowing Qiagen to compete in the open federal marketplace. The award is for delivery to Germantown, Maryland, where Qiagen maintains its headquarters operations. As a foreign-owned manufacturer specializing in molecular diagnostics, scientific equipment, and bioinformatics...
- Qiagen, LLC received a $14,706 Firm Fixed Price contract award on November 8, 2017, through a Blanket Purchase Agreement (BPA) call with the Office of Logistics and Acquisition Operations, a civilian agency. The contract is classified as an "In Vitro" procurement with an ultimate completion date of April 30, 2018, and will be performed in Germantown, Maryland. No set-aside designation was applied to this award, indicating open competitive procurement. As a foreign-owned molecular...
- This federal contract award extends a service agreement with Qiagen, LLC, a subsidiary of Qiagen N.V., a global biotechnology company. The $12,063 firm fixed-price purchase order was awarded by the Pacific West Area of a civilian federal agency. The contract has a one-year period of performance, with a completion date of September 28, 2024. No set-aside designation was used. Qiagen is a long-standing provider of specialized products and services to support federal agencies' biomedical...
- Qiagen, LLC, a Germantown, Maryland-based manufacturer of molecular diagnostics and scientific equipment, was awarded an $20,805.12 firm fixed price blanket purchase agreement (BPA) call by a civilian federal agency's Office of Logistics and Acquisition Operations on August 24, 2017. The contract, classified as an in vitro substance procurement, was completed by April 30, 2018, with performance conducted in Germantown, Maryland. No set-aside designation was applied to this award, allowing the...
- Qiagen, LLC, a foreign-owned molecular diagnostics manufacturer headquartered in Germantown, Maryland, received a Blanket Purchase Agreement (BPA) call award on November 20, 2019, from the Office of Logistics and Acquisition Operations for chemicals. The contract, which operated under a firm fixed price structure with no set-aside designation, carried a ceiling value of $20,409.60 and an ultimate completion date of April 30, 2020. Performance was conducted at Qiagen's Germantown, Maryland...
- Qiagen, LLC received a $14,480.64 Firm Fixed Price Blanket Purchase Agreement (BPA) call award from the Office of Logistics and Acquisition Operations, a civilian federal agency, for the procurement of chemicals. The contract was awarded on April 14, 2015, with an ultimate completion date of April 30, 2024, and will be performed in Valencia, California. This award was made without a set-aside designation, indicating Qiagen's ability to compete in the open federal marketplace. Qiagen, LLC is a...
- Qiagen, LLC, a foreign-owned molecular diagnostics manufacturer headquartered in Germantown, Maryland, was awarded a Blanket Purchase Agreement (BPA) call valued at $22,817.52 for chemicals on December 10, 2018. The contract, issued by the Office of Logistics and Acquisition Operations, a civilian federal agency, carries a firm fixed price structure with no set-aside designation, reflecting Qiagen's competitive standing in the open federal marketplace. Work is to be performed in Germantown,...